Potent and Selective Aminopyrimidine-Based B-Raf Inhibitors with Favorable Physicochemical and Pharmacokinetic Properties
Journal Article
·
· J. Med. Chem. 55:2869-2881,2012
OSTI ID:1095062
- Research Organization:
- SLAC National Accelerator Lab., Menlo Park, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1095062
- Report Number(s):
- SLAC-REPRINT-2013-792
- Journal Information:
- J. Med. Chem. 55:2869-2881,2012, Journal Name: J. Med. Chem. 55:2869-2881,2012
- Country of Publication:
- United States
- Language:
- English
Similar Records
Identification of C -2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2
Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase With Potent Antimelanoma Activity
Synthesis, Biological Evaluation, X-Ray Structure, and Pharmacokinetics of Aminopyrimidine C-Jun-N-Terminal Kinase (JNK) Inhibitors
Journal Article
·
Fri May 31 00:00:00 EDT 2013
· Journal of Medicinal Chemistry
·
OSTI ID:1095062
+44 more
Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase With Potent Antimelanoma Activity
Journal Article
·
Tue May 26 00:00:00 EDT 2009
· Proc. Nat. Acad. Sci. 105:3041,2008
·
OSTI ID:1095062
+18 more
Synthesis, Biological Evaluation, X-Ray Structure, and Pharmacokinetics of Aminopyrimidine C-Jun-N-Terminal Kinase (JNK) Inhibitors
Journal Article
·
Thu Jul 11 00:00:00 EDT 2013
· J. Med. Chem 53:419,2010
·
OSTI ID:1095062
+12 more